Cargando…
Concurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer
BACKGROUND: Despite broad advances in multimodal treatment of locally advanced breast cancer (LABC), 30 to 40% of patients develop loco-regional relapse. The aim of this study was to analyze in a retrospective manner the effectiveness of concurrent chemo-radiotherapy (CCRTh) after neoadjuvant chemot...
Autores principales: | Alvarado-Miranda, Alberto, Arrieta, Oscar, Gamboa-Vignolle, Carlos, Saavedra-Perez, David, Morales-Barrera, Rafael, Bargallo-Rocha, Enrique, Zinser-Sierra, Juan, Perez-Sanchez, Victor, Ramirez-Ugalde, Teresa, Lara-Medina, Fernando |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716349/ https://www.ncbi.nlm.nih.gov/pubmed/19591689 http://dx.doi.org/10.1186/1748-717X-4-24 |
Ejemplares similares
-
Concurrent chemo-radiotherapy with proton therapy: reduced toxicity with comparable oncological outcomes vs photon chemo-radiotherapy
por: Baumann, Brian C., et al.
Publicado: (2020) -
Identification of protein clusters predictive of tumor response in rectal cancer patients receiving neoadjuvant chemo-radiotherapy
por: Repetto, Ombretta, et al.
Publicado: (2017) -
Systemic Effects of Radiotherapy and Concurrent Chemo-Radiotherapy in Head and Neck Cancer Patients—Comparison of Serum Metabolome Profiles
por: Jelonek, Karol, et al.
Publicado: (2020) -
Adriamycin-Cyclophosphamide (AC) followed by Paclitaxel-Cisplatin (PC). A highly active neoadjuvant regimen in locally advanced breast cancer
por: Mendoza-Posada, Daniel, et al.
Publicado: (2007) -
Clinical and Epidemiological Profile of Breast Cancer in Mexico: Results of the Seguro Popular
por: Reynoso-Noverón, Nancy, et al.
Publicado: (2017)